Skip to main content
Log in

A Fixed Combination of Cinnarizine/Dimenhydrinate for the Treatment of Patients with Acute Vertigo Due to Vestibular Disorders

A Randomized, Reference-Controlled Clinical Study

  • Original Research Article
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Background and objective: Vestibular dysfunction commonly leads to — often severe — vertigo symptoms. The objective of this study was to compare the antivertiginous efficacy and tolerability of a fixed combination of cinnarizine/dimenhydrinate with those of betahistine in patients with acute vertigo due to vestibular disorders.

Methods: Sixty-six patients experiencing acute vertigo attacks participated in this prospective, double-blind, three-centre, comparative study. Patients who assessed at least one vertigo symptom as being of medium intensity (≥2) on a 5-point visual analogue scale (VAS; from 0 = no symptoms to 4 = very severe symptoms) were randomly allocated to treatment with the fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg three times daily or betahistine 12 mg three times daily for 4 weeks. The primary efficacy endpoint was change in mean vertigo score, as determined by patients’ assessments of 12 individual vertigo symptoms on the 5-point VAS after 4 weeks of treatment.

Results: Treatment with the fixed combination led to significantly greater improvements in mean vertigo scores than the reference therapy betahistine after 4 weeks of therapy (p = 0.013). The differences were clinically relevant, based on the Mann-Whitney estimator. Furthermore, the incidence of vertigo-associated vegetative symptoms was significantly reduced after 1 (p = 0.004) and 4 weeks (p = 0.023) in the fixed-combination group relative to the betahistine group. Three patients, all of them in the betahistine group, reported adverse events, none of which was considered serious. Almost all patients (n = 62) rated the tolerabilities of both medications as very good or good.

Conclusion: The fixed combination of cinnarizine/dimenhydrinate was shown to be an effective and very well tolerated treatment option for patients with acute vertigo due to vestibular disorders. The combination proved to be significantly more efficient in reducing vertigo and associated vegetative symptoms than betahistine in such patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II
Table III
Table IV
Table V

Similar content being viewed by others

References

  1. Smith DB. Dizziness: the history and physical examination. In: Arenberg IK, editor. Dizziness and balance disorders. Amsterdam: Kugler Publications, 1993: 3–10

    Google Scholar 

  2. Luxon LM. Evaluation and management of the dizzy patient. J Neurol Neurosurg Psychiatry 2004; 75 Suppl. 4: iv45–52

    Article  Google Scholar 

  3. Nashner LM, Shupert CL, Horak FB, et al. Organization of posture controls: an analysis of sensory and mechanical constraints. Prog Brain Res 1989; 80: 411–8

    Article  PubMed  CAS  Google Scholar 

  4. Bird JC, Beynon GJ, Prevost AT, et al. An analysis of referral patterns for dizziness in the primary care setting. Br J Gen Pract 1998; 48: 1828–32

    PubMed  CAS  Google Scholar 

  5. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs 2003; 17: 85–100

    Article  PubMed  CAS  Google Scholar 

  6. Novotny M, Kostrica R, Cirek Z. The efficacy of Arlevert therapy for vertigo and tinnitus. Int Tinnitus J 1999; 5: 60–2

    PubMed  CAS  Google Scholar 

  7. Schremmer D, Bognar-Steinberg I, Baumann W, et al. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate in treatment of vertigo: analysis of data from five randomised, double-blind clinical studies. Clin Drug Invest 1999; 18: 355–68

    Article  CAS  Google Scholar 

  8. Novotny M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Meniere’s disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 2002; 8: 115–23

    PubMed  CAS  Google Scholar 

  9. Scholtz AW, Schwarz M, Baumann W, et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther 2004; 26: 866–77

    Article  PubMed  CAS  Google Scholar 

  10. Cirek Z, Schwarz M, Baumann W, et al. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo: a double-blind, randomised clinical study. Clin Drug Invest 2005; 25: 377–89

    Article  CAS  Google Scholar 

  11. Pytel J, Nagy G, Toth A, et al. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther 2007; 29: 84–98

    Article  PubMed  CAS  Google Scholar 

  12. Ben-David J, Podoshin L, Fradis M. A comparative cranio-corpography study on the findings in the Romberg standing test versus the Unterberger/Fukuda stepping test in vertigo patients. Acta Otorhinolaryngol Belg 1985; 39: 924–32

    PubMed  CAS  Google Scholar 

  13. Bojrab DI, Stockwell CW. Electronystagmography and rotation tests. In: Jackler RK, Brackmann DE, editors. Neurotology. St Louis (MO): Mosby-Year Book, 1994: 219–28

    Google Scholar 

  14. Jongkees LB. Which is the preferable method to perform the caloric test? Arch Otolaryngol 1949; 49: 594–608

    Article  PubMed  CAS  Google Scholar 

  15. Colditz GA, Miller JN, Mosteller F. Measuring gain in the evaluation of medical technology: the probability of a better outcome. Int J Technol Assess Health Care 1988; 4: 637–42

    Article  PubMed  CAS  Google Scholar 

  16. Bojrab DI, Bhansali SA, Battista RA.Peripheral vestibular disorders. In: {Jackler RK, Brackmann DE}, editors. Neurotology. St Louis (MO): Mosby-Year Book, 1994: 629–49

  17. Stoll W. Otogenic vertigo: differentiation and therapy. Laryngorhinootologie 1993; 72: 311–5

    Article  PubMed  CAS  Google Scholar 

  18. Godfraind T, Towse G, Van Nueten JM. Cinnarizine: a selective calcium entry blocker. Drugs Today 1982; 18: 27–42

    CAS  Google Scholar 

  19. Arab SF, Duwel P, Jungling E, et al. Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 570–5

    Article  PubMed  CAS  Google Scholar 

  20. Duwel P, Haasler T, Jungling E, et al. Effects of cinnarizine on calcium and pressure-dependent potassium currents in guinea pig vestibular hair cells. Naunyn Schmiedebergs Arch Pharmacol 2005; 371: 441–8

    Article  PubMed  Google Scholar 

  21. Jaju BP, Wang SC. Effects of diphenhydramine and dimenhydrinate on vestibular neuronal activity of cat: a search for the locus of their antimotion sickness action. J Pharmacol Exp Ther 1971; 176: 718–24

    PubMed  CAS  Google Scholar 

  22. Martinez DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol 1972; 305 Suppl.: 29–47

    Article  CAS  Google Scholar 

  23. Snow JB, Suga F. Control of the microcirculation of the inner ear. Otolaryngol Clin North Am 1975; 8: 455–66

    PubMed  Google Scholar 

  24. Fischer AJ. Histamine in the treatment of vertigo. Acta Otolaryngol Suppl 1991; 479: 24–8

    Article  PubMed  CAS  Google Scholar 

  25. Schneider D, Kiessling B, Wieczorek M, et al. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers. Int J Clin Pharmacol Ther 2003; 41: 171–81

    PubMed  CAS  Google Scholar 

  26. Philipova D, Tzenova B, Iwanowitsch A, et al. Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance: a randomized, double-blind, 3-way crossover study in healthy volunteers. Int J Clin Pharmacol Ther 2004; 42: 218–31

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The conduct, statistical analysis and publication of this study were funded by Hennig Arzneimittel, Floersheim am Main, Germany. The authors thank Andreas Iwanowitsch for statistical analysis. W. Baumann and M. Schwarz, and study statistician A. Iwanowitsch, are employees of the study sponsor. The other authors have no potential conflicts of interest that are directly relevant to the content of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Schwarz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hahn, A., Sejna, I., Stefflova, B. et al. A Fixed Combination of Cinnarizine/Dimenhydrinate for the Treatment of Patients with Acute Vertigo Due to Vestibular Disorders. Clin. Drug Investig. 28, 89–99 (2008). https://doi.org/10.2165/00044011-200828020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200828020-00003

Keywords

Navigation